(MTX) Minerals Technologies - Overview
Stock: Pet Litter, Calcium Carbonate, Refractory Linings, Geosynthetic Clay, Filtration
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.74% |
| Yield on Cost 5y | 0.84% |
| Yield CAGR 5y | 22.47% |
| Payout Consistency | 96.2% |
| Payout Ratio | 6.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | -7.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -17.72 |
| Character TTM | |
|---|---|
| Beta | 0.885 |
| Beta Downside | 0.901 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.47% |
| CAGR/Max DD | 0.16 |
Description: MTX Minerals Technologies January 15, 2026
Minerals Technologies Inc. (NYSE:MTX) manufactures mineral-based products and services across two business segments: Consumer & Specialties and Engineered Solutions.
The Consumer & Specialties segment sells household and personal-care items-including pet litter, fabric care, and edible-oil purification-under brands such as PREMIUM CHOICE, VitaLife, and ENERSOL, and also supplies precipitated and ground calcium carbonate additives to paper, packaging, automotive, and construction markets.
The Engineered Solutions segment focuses on high-temperature mineral blends for casting automotive and heavy-truck parts, as well as environmental-infrastructure products like geosynthetic clay liners, vapor-intrusion barriers, green-roof systems, and water-purification technologies; it also offers refractory monoliths, carbon composites (PYROID), and related testing services.
MTX operates globally-U.S., Canada, Latin America, Europe, Africa, and Asia-primarily through a direct sales force supplemented by regional distributors.
Recent financials show FY 2023 revenue of roughly $1.5 billion, with an adjusted EBITDA margin near 10 % and a cash-flow conversion rate of about 85 %, indicating solid operating efficiency despite cyclical demand in the refractory market.
Key economic drivers include rising U.S. infrastructure spending under the 2021 Infrastructure Investment and Jobs Act and growing demand for sustainable packaging, both of which boost demand for MTX’s calcium-carbonate additives and engineered casting solutions.
For a data-rich, objective view of MTX’s valuation metrics and scenario analysis, you may find ValueRay’s platform worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -18.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.43 > 1.0 |
| NWC/Revenue: 28.96% < 20% (prev 34.61%; Δ -5.66% < -1%) |
| CFO/TA 0.06 > 3% & CFO 199.8m > Net Income -18.5m |
| Net Debt (632.7m) to EBITDA (145.9m): 4.34 < 3 |
| Current Ratio: 2.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.1m) vs 12m ago -3.72% < -2% |
| Gross Margin: 24.99% > 18% (prev 0.26%; Δ 2473 % > 0.5%) |
| Asset Turnover: 60.40% > 50% (prev 62.42%; Δ -2.02% > 0%) |
| Interest Coverage Ratio: 0.79 > 6 (EBITDA TTM 145.9m / Interest Expense TTM 54.5m) |
Altman Z'' 4.57
| A: 0.17 (Total Current Assets 1.16b - Total Current Liabilities 555.4m) / Total Assets 3.47b |
| B: 0.71 (Retained Earnings 2.45b / Total Assets 3.47b) |
| C: 0.01 (EBIT TTM 43.0m / Avg Total Assets 3.43b) |
| D: 1.00 (Book Value of Equity 1.71b / Total Liabilities 1.72b) |
| Altman-Z'' Score: 4.57 = AA |
Beneish M -3.01
| DSRI: 1.06 (Receivables 400.1m/385.2m, Revenue 2.07b/2.12b) |
| GMI: 1.03 (GM 24.99% / 25.85%) |
| AQI: 1.03 (AQ_t 0.37 / AQ_t-1 0.36) |
| SGI: 0.98 (Revenue 2.07b / 2.12b) |
| TATA: -0.06 (NI -18.5m - CFO 199.8m) / TA 3.47b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of MTX shares?
Over the past week, the price has changed by +10.66%, over one month by +13.83%, over three months by +31.12% and over the past year by -3.80%.
Is MTX a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 83 | 14.1% |
| Analysts Target Price | 83 | 14.1% |
| ValueRay Target Price | 72.7 | -0.1% |
MTX Fundamental Data Overview February 01, 2026
P/S = 0.9962
P/B = 1.2127
P/EG = 2.2637
Revenue TTM = 2.07b USD
EBIT TTM = 43.0m USD
EBITDA TTM = 145.9m USD
Long Term Debt = 957.8m USD (from longTermDebt, two quarters ago)
Short Term Debt = 6.70m USD (from shortTermDebt, last quarter)
Debt = 961.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 632.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.69b USD (2.06b + Debt 961.7m - CCE 332.6m)
Interest Coverage Ratio = 0.79 (Ebit TTM 43.0m / Interest Expense TTM 54.5m)
EV/FCF = 27.76x (Enterprise Value 2.69b / FCF TTM 97.0m)
FCF Yield = 3.60% (FCF TTM 97.0m / Enterprise Value 2.69b)
FCF Margin = 4.68% (FCF TTM 97.0m / Revenue TTM 2.07b)
Net Margin = -0.89% (Net Income TTM -18.5m / Revenue TTM 2.07b)
Gross Margin = 24.99% ((Revenue TTM 2.07b - Cost of Revenue TTM 1.55b) / Revenue TTM)
Gross Margin QoQ = 23.97% (prev 25.73%)
Tobins Q-Ratio = 0.78 (Enterprise Value 2.69b / Total Assets 3.47b)
Interest Expense / Debt = 1.34% (Interest Expense 12.9m / Debt 961.7m)
Taxrate = 20.0% (9.60m / 48.0m)
NOPAT = 34.4m (EBIT 43.0m * (1 - 20.00%))
Current Ratio = 2.08 (Total Current Assets 1.16b / Total Current Liabilities 555.4m)
Debt / Equity = 0.56 (Debt 961.7m / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 4.34 (Net Debt 632.7m / EBITDA 145.9m)
Debt / FCF = 6.52 (Net Debt 632.7m / FCF TTM 97.0m)
Total Stockholder Equity = 1.66b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.54% (Net Income -18.5m / Total Assets 3.47b)
RoE = -1.11% (Net Income TTM -18.5m / Total Stockholder Equity 1.66b)
RoCE = 1.64% (EBIT 43.0m / Capital Employed (Equity 1.66b + L.T.Debt 957.8m))
RoIC = 1.31% (NOPAT 34.4m / Invested Capital 2.62b)
WACC = 6.60% (E(2.06b)/V(3.02b) * Re(9.18%) + D(961.7m)/V(3.02b) * Rd(1.34%) * (1-Tc(0.20)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.18%
[DCF Debug] Terminal Value 82.76% ; FCFF base≈129.2m ; Y1≈121.9m ; Y5≈115.0m
Fair Price DCF = 69.73 (EV 2.80b - Net Debt 632.7m = Equity 2.17b / Shares 31.1m; r=6.60% [WACC]; 5y FCF grow -7.24% → 2.90% )
EPS Correlation: 23.92 | EPS CAGR: -1.81% | SUE: -0.10 | # QB: 0
Revenue Correlation: -37.61 | Revenue CAGR: 0.02% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.27 | Chg30d=-0.090 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=6.17 | Chg30d=-0.018 | Revisions Net=-2 | Growth EPS=+11.8% | Growth Revenue=+4.1%
EPS next Year (2027-12-31): EPS=6.96 | Chg30d=-0.415 | Revisions Net=+0 | Growth EPS=+12.7% | Growth Revenue=+4.0%